Market Tracker

08/18 5:16pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

3.23
Delayed Data
As of Aug 18
 +0.15 / +4.87%
Today’s Change
1.97
Today|||52-Week Range
5.78
+49.62%
Year-to-Date

Today’s Trading

Previous close3.08
Today’s open3.04
Day’s range2.99 - 3.27
Volume192,200
Average volume (3 months)241,142
Market cap$145.6M
Dividend yield--
Data as of 3:59pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+55.10%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+28.97%
P/E ratioNM
Price/Sales2.77
Price/Book2.65

Competitors

 Today’s
change
Today’s
% change
ADMPAdamis Pharmaceutica...+0.05+1.10%
CNATConatus Pharmaceutic...-0.12-2.34%
MRTXMirati Therapeutics ...+0.55+10.89%
TRVNTrevena Inc-0.04-1.68%
Data as of 3:59pm ET, 08/18/2017

Financials

Next reporting dateSeptember 8, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$57.6M
Annual profit (last year)-$28.2M
Net profit margin-48.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts